Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial (Q30789784)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial |
scientific article |
Statements
1 reference
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial (English)
1 reference
Philipp von Rosenstiel
1 reference
Ludwig Kappos
1 reference
Peter A Calabresi
1 reference
Ernst-Wilhelm Radue
1 reference
Tracy Stites
1 reference
Kottil W Rammohan
1 reference
Fred D Lublin
1 reference
Douglas Goodin
1 reference
Douglas Jeffery
1 reference
Anthony T Reder
1 reference
Timothy Vollmer
1 reference
Mark A Agius
1 reference
Bingbing Li
1 reference
Linda Cappiello
1 reference
28 March 2014
1 reference
1 reference
13
1 reference
545-556
1 reference
Identifiers
1 reference
1 reference